Scientists reprogram so-called MHC molecules, responsible for displaying antigens, to match donor to receipient for Transplantation surgery, using CRISPR/Cas9. After breakthroughs in allogenic iPSC treatment of AMD in Japan, this technique could help prevent GvHD in allogeneic transplantation.

See the source article by following the link below:
Scientists reprogram so-called MHC molecules, responsible for displaying antigens, to match donor to receipient for Transplantation surgery, using CRISPR/Cas9. After breakthroughs in allogenic iPSC treatment of AMD in Japan, this technique could help prevent GvHD in allogeneic transplantation.